Male contraceptives
AssigneeNorth Shore University Hospital
InventorSusan H. Benoff
Life of this patent
Estimating the term…
Abstract
Methods for achieving human male contraception are described in which compounds that substantially inhibit the movement of mannose lectins on the surface of human male sperm cells are administered to human male patients, and the inhibition achieved provides a reversible infertility that can serve as a means of birth control. The use of calcium (Ca.sup.+2) ion channel blocking pharmaceutical compositions is described, particularly the drugs nifedipine, verapamil, and calcium ionophore A23187.
Claims9
A reversible method of human male contraception which comprises producing a period of infertility in a fertile male patient by systemically administering a pharmaceutical composition that substantially inhibits the migration of mannose lectins on the surface of said patient's sperm cells to said patient for a time and in an amount sufficient to render said patient infertile.
A reversible method of human male contraception which comprises producing a period of infertility in a fertile male patient by systemic administration of a calcium (Ca.sup.2+) ion channel blocker to said patient for a time and in an amount sufficient to substantially inhibit the migration of mannose lectins on the surface of said patient's sperm cells.
A reversible method of human male contraception which comprises administering a calcium (Ca.sup.2+) ion channel blocker to a fertile male patient for a time and in an amount sufficient to produce a period of infertility in said patient.
Dependencies are inferred from the claim text.